Additionally, the magnitude of peripheral metabolic effects, like insulin secretion, glucagon suppression, and modulation of gut hormones, can also be influenced by a patient’s existing metabolic status and degree of insulin resistance [29,30]. The gene discussed is INS; the disease is Insulin resistance.